Tuberculosis Diagnosis and Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 100 pages | ID: T93CD4EA66E3EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Tuberculosis Diagnosis and Treatment in Global, including the following market information:

Global Tuberculosis Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tuberculosis Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Laboratory Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tuberculosis Diagnosis and Treatment include Abbott Laboratories, Akonni Biosystems, Thermo Fisher Scientific, BD, Bio-Synth, bioM?rieux, Cepheid, Eiken Chemical and Epistem, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tuberculosis Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tuberculosis Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tuberculosis Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)

• Laboratory Testing
• Nucleic Acid Tests
• Mantoux Test
• Radiography
• Drug Susceptibility Test

Global Tuberculosis Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tuberculosis Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Government organizations
• Individual

Global Tuberculosis Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tuberculosis Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tuberculosis Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tuberculosis Diagnosis and Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Akonni Biosystems
• Thermo Fisher Scientific
• BD
• Bio-Synth
• bioM?rieux
• Cepheid
• Eiken Chemical
• Epistem
• Roche
• GSK
• Hain Lifesciences
• Hologic
• Labatec
• Lupin
• Otsuka Novel Products
• QIAGEN
• Sandoz
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tuberculosis Diagnosis and Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tuberculosis Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TUBERCULOSIS DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE

2.1 Global Tuberculosis Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Tuberculosis Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tuberculosis Diagnosis and Treatment Players in Global Market
3.2 Top Global Tuberculosis Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Tuberculosis Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Tuberculosis Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tuberculosis Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tuberculosis Diagnosis and Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Tuberculosis Diagnosis and Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tuberculosis Diagnosis and Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tuberculosis Diagnosis and Treatment Market Size Markets, 2021 & 2028
  4.1.2 Laboratory Testing
  4.1.3 Nucleic Acid Tests
  4.1.4 Mantoux Test
  4.1.5 Radiography
  4.1.6 Drug Susceptibility Test
4.2 By Type - Global Tuberculosis Diagnosis and Treatment Revenue & Forecasts
  4.2.1 By Type - Global Tuberculosis Diagnosis and Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Tuberculosis Diagnosis and Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tuberculosis Diagnosis and Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Government organizations
  5.1.4 Individual
5.2 By Application - Global Tuberculosis Diagnosis and Treatment Revenue & Forecasts
  5.2.1 By Application - Global Tuberculosis Diagnosis and Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Tuberculosis Diagnosis and Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tuberculosis Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Tuberculosis Diagnosis and Treatment Revenue & Forecasts
  6.2.1 By Region - Global Tuberculosis Diagnosis and Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Tuberculosis Diagnosis and Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tuberculosis Diagnosis and Treatment Revenue, 2017-2028
  6.3.2 US Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.3.3 Canada Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.3.4 Mexico Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tuberculosis Diagnosis and Treatment Revenue, 2017-2028
  6.4.2 Germany Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.4.3 France Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.4.4 U.K. Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.4.5 Italy Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.4.6 Russia Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.4.8 Benelux Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tuberculosis Diagnosis and Treatment Revenue, 2017-2028
  6.5.2 China Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.5.3 Japan Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.5.4 South Korea Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.5.6 India Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tuberculosis Diagnosis and Treatment Revenue, 2017-2028
  6.6.2 Brazil Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.6.3 Argentina Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue, 2017-2028
  6.7.2 Turkey Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.7.3 Israel Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Tuberculosis Diagnosis and Treatment Market Size, 2017-2028
  6.7.5 UAE Tuberculosis Diagnosis and Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.1.4 Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Akonni Biosystems
  7.2.1 Akonni Biosystems Corporate Summary
  7.2.2 Akonni Biosystems Business Overview
  7.2.3 Akonni Biosystems Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.2.4 Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.2.5 Akonni Biosystems Key News
7.3 Thermo Fisher Scientific
  7.3.1 Thermo Fisher Scientific Corporate Summary
  7.3.2 Thermo Fisher Scientific Business Overview
  7.3.3 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.3.4 Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.3.5 Thermo Fisher Scientific Key News
7.4 BD
  7.4.1 BD Corporate Summary
  7.4.2 BD Business Overview
  7.4.3 BD Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.4.4 BD Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.4.5 BD Key News
7.5 Bio-Synth
  7.5.1 Bio-Synth Corporate Summary
  7.5.2 Bio-Synth Business Overview
  7.5.3 Bio-Synth Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.5.4 Bio-Synth Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.5.5 Bio-Synth Key News
7.6 bioM?rieux
  7.6.1 bioM?rieux Corporate Summary
  7.6.2 bioM?rieux Business Overview
  7.6.3 bioM?rieux Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.6.4 bioM?rieux Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.6.5 bioM?rieux Key News
7.7 Cepheid
  7.7.1 Cepheid Corporate Summary
  7.7.2 Cepheid Business Overview
  7.7.3 Cepheid Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.7.4 Cepheid Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.7.5 Cepheid Key News
7.8 Eiken Chemical
  7.8.1 Eiken Chemical Corporate Summary
  7.8.2 Eiken Chemical Business Overview
  7.8.3 Eiken Chemical Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.8.4 Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.8.5 Eiken Chemical Key News
7.9 Epistem
  7.9.1 Epistem Corporate Summary
  7.9.2 Epistem Business Overview
  7.9.3 Epistem Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.9.4 Epistem Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.9.5 Epistem Key News
7.10 Roche
  7.10.1 Roche Corporate Summary
  7.10.2 Roche Business Overview
  7.10.3 Roche Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.10.4 Roche Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.10.5 Roche Key News
7.11 GSK
  7.11.1 GSK Corporate Summary
  7.11.2 GSK Business Overview
  7.11.3 GSK Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.11.4 GSK Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.11.5 GSK Key News
7.12 Hain Lifesciences
  7.12.1 Hain Lifesciences Corporate Summary
  7.12.2 Hain Lifesciences Business Overview
  7.12.3 Hain Lifesciences Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.12.4 Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.12.5 Hain Lifesciences Key News
7.13 Hologic
  7.13.1 Hologic Corporate Summary
  7.13.2 Hologic Business Overview
  7.13.3 Hologic Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.13.4 Hologic Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.13.5 Hologic Key News
7.14 Labatec
  7.14.1 Labatec Corporate Summary
  7.14.2 Labatec Business Overview
  7.14.3 Labatec Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.14.4 Labatec Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.14.5 Labatec Key News
7.15 Lupin
  7.15.1 Lupin Corporate Summary
  7.15.2 Lupin Business Overview
  7.15.3 Lupin Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.15.4 Lupin Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.15.5 Lupin Key News
7.16 Otsuka Novel Products
  7.16.1 Otsuka Novel Products Corporate Summary
  7.16.2 Otsuka Novel Products Business Overview
  7.16.3 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.16.4 Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.16.5 Otsuka Novel Products Key News
7.17 QIAGEN
  7.17.1 QIAGEN Corporate Summary
  7.17.2 QIAGEN Business Overview
  7.17.3 QIAGEN Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.17.4 QIAGEN Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.17.5 QIAGEN Key News
7.18 Sandoz
  7.18.1 Sandoz Corporate Summary
  7.18.2 Sandoz Business Overview
  7.18.3 Sandoz Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.18.4 Sandoz Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.18.5 Sandoz Key News
7.19 Sanofi
  7.19.1 Sanofi Corporate Summary
  7.19.2 Sanofi Business Overview
  7.19.3 Sanofi Tuberculosis Diagnosis and Treatment Major Product Offerings
  7.19.4 Sanofi Tuberculosis Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.19.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tuberculosis Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Tuberculosis Diagnosis and Treatment Market Drivers in Global Market
Table 3. Tuberculosis Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Tuberculosis Diagnosis and Treatment in Global Market
Table 5. Top Tuberculosis Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tuberculosis Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tuberculosis Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tuberculosis Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Tuberculosis Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tuberculosis Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tuberculosis Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tuberculosis Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tuberculosis Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tuberculosis Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Tuberculosis Diagnosis and Treatment Product Offerings
Table 32. Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Akonni Biosystems Corporate Summary
Table 34. Akonni Biosystems Tuberculosis Diagnosis and Treatment Product Offerings
Table 35. Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Thermo Fisher Scientific Corporate Summary
Table 37. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Product Offerings
Table 38. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. BD Corporate Summary
Table 40. BD Tuberculosis Diagnosis and Treatment Product Offerings
Table 41. BD Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Synth Corporate Summary
Table 43. Bio-Synth Tuberculosis Diagnosis and Treatment Product Offerings
Table 44. Bio-Synth Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 45. bioM?rieux Corporate Summary
Table 46. bioM?rieux Tuberculosis Diagnosis and Treatment Product Offerings
Table 47. bioM?rieux Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Cepheid Corporate Summary
Table 49. Cepheid Tuberculosis Diagnosis and Treatment Product Offerings
Table 50. Cepheid Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Eiken Chemical Corporate Summary
Table 52. Eiken Chemical Tuberculosis Diagnosis and Treatment Product Offerings
Table 53. Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Epistem Corporate Summary
Table 55. Epistem Tuberculosis Diagnosis and Treatment Product Offerings
Table 56. Epistem Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Roche Corporate Summary
Table 58. Roche Tuberculosis Diagnosis and Treatment Product Offerings
Table 59. Roche Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 60. GSK Corporate Summary
Table 61. GSK Tuberculosis Diagnosis and Treatment Product Offerings
Table 62. GSK Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Hain Lifesciences Corporate Summary
Table 64. Hain Lifesciences Tuberculosis Diagnosis and Treatment Product Offerings
Table 65. Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Hologic Corporate Summary
Table 67. Hologic Tuberculosis Diagnosis and Treatment Product Offerings
Table 68. Hologic Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Labatec Corporate Summary
Table 70. Labatec Tuberculosis Diagnosis and Treatment Product Offerings
Table 71. Labatec Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Lupin Corporate Summary
Table 73. Lupin Tuberculosis Diagnosis and Treatment Product Offerings
Table 74. Lupin Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Otsuka Novel Products Corporate Summary
Table 76. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Product Offerings
Table 77. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 78. QIAGEN Corporate Summary
Table 79. QIAGEN Tuberculosis Diagnosis and Treatment Product Offerings
Table 80. QIAGEN Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Sandoz Corporate Summary
Table 82. Sandoz Tuberculosis Diagnosis and Treatment Product Offerings
Table 83. Sandoz Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Sanofi Corporate Summary
Table 85. Sanofi Tuberculosis Diagnosis and Treatment Product Offerings
Table 86. Sanofi Tuberculosis Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tuberculosis Diagnosis and Treatment Segment by Type in 2021
Figure 2. Tuberculosis Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global Tuberculosis Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tuberculosis Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tuberculosis Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tuberculosis Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tuberculosis Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tuberculosis Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Akonni Biosystems Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Thermo Fisher Scientific Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BD Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Synth Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. bioM?rieux Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cepheid Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eiken Chemical Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Epistem Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Roche Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GSK Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Hain Lifesciences Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Hologic Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Labatec Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Lupin Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Otsuka Novel Products Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. QIAGEN Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Sandoz Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Sanofi Tuberculosis Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)